Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The development of the retinal vascular network is generally complete during the 3rd trimester of pregnancy but may continue during the first 15 days of life. This late maturation may cause problems in pre-term births and may result in immature vascularization of the retina, a condition called retinopathy of prematurity. Among the different factors affecting the development of the retinal vasculature, the tissue level of omega-3 polyunsaturated fatty acids (PUFA) appears to be a crucial element, as does the form of the PUFA present in the tissues (nature of the phospholipids in their membranes). This project aims to show a possible association between levels of omega-3 PUFA and the onset of retinopathy of prematurity (ROP).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity

NCT00279669

Retinopathy of Prematurity

COMPLETED

Premavision Cohort Follow-up

NCT03207477

Visual Disorder

TERMINATED NA

Preterm Infants REtinalMicrovascular Alterations by Means of OCT Angiography

NCT05699668

Premature With Dysplasia Bronchopulmonary Premature Without Dysplasia Bronchopulmonary Controls Born at Term

UNKNOWN NA

Role of Cord Blood Cytokines and Perinatal Factors in Prediction of Retinopathy of Prematurity

NCT04769661

Retinopathy of Prematurity

UNKNOWN

Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

NCT04995341

Retinopathy of Prematurity

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinopathy of Prematurity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RETCAM

Group Type EXPERIMENTAL

RETCAM

Intervention Type OTHER

Blood samples

Intervention Type BIOLOGICAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RETCAM

Intervention Type OTHER

Blood samples

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Premature new-born infants born at less than 29 weeks of amenorrhea after informed consent has been obtained from a parent or the legal guardian of the infant